The Crohn's Disease-Associated Bacterial Protein I2 Is a Novel Enteric T Cell Superantigen  by Dalwadi, Harnisha et al.
Immunity, Vol. 15, 149–158, July, 2001, Copyright 2001 by Cell Press
The Crohn’s Disease-Associated Bacterial Protein
I2 Is a Novel Enteric T Cell Superantigen
and antibiotic therapy (Janowitz et al., 1998; Prantera
et al., 1996; Gui et al., 1997) and association with a strong
humoral immune response to several enteric bacterial
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1 Department of Pathology and Laboratory Medicine species (Blaser et al., 1984; Elsaghier et al., 1992; Dar-
feuille-Michaud et al., 1998).2 Molecular Biology Institute
University of California, Los Angeles Several animal IBD models have been developed, in
which spontaneous or transgenic mutations or transferSchool of Medicine
Los Angeles, California 90095 of certain T cell subsets renders mice susceptible to
chronic intestinal inflammation. The relationship of these3 La Jolla Institute of Allergy and Immunology
La Jolla, California 92121 models to human disease is imperfect (Sartor, 1997).
However, IL-10/ and Gi2/colitic mice display human
CD-like features, notably predominant Th1 activity of
the mucosal CD4 T cell population and transmuralSummary
mononuclear inflammation (Berg et al., 1996; Hornquist
et al., 1997). In contrast, IL-2/ and TCR/ mice haveAn aberrant T cell response to enteric bacteria is im-
UC-like features, including predominant Th2 activationportant in inflammatory bowel disease. However, the
and superficial mucosal inflammation (Sadlack et al.,identity of relevant microbial antigens is unknown.
1993; Mombaerts et al., 1998; Sartor, 1997). In all theseHere, we report the presence of I2, a Crohn’s disease-
models, disease does not develop when mice areassociated microbial gene, in the murine intestine. The
housed in a germ-free or specific pathogen-free environ-I2 protein induced a proliferative and IL-10 response by
ment, indicating that microorganisms play an importantCD4 T cells from unimmunized mice. The I2 response
role in mediating intestinal pathogenesis. Elson and col-was dependent on MHC class II-mediated recognition
leagues have further developed this point by demonstra-but did not require antigen processing. Selective acti-
ting a specific humoral and CD4 T cell response tovation was observed for the TCR-V5 subpopulation.
intestinal bacteria in the C3H/HeJBir colitis mouseThese findings indicate that the I2 protein is a new
model (Cong et al., 1998). This group has further shownclass of T cell superantigen and suggest that coloniza-
that certain bacteria-specific CD4 T cell lines transfertion by the I2 microorganism in susceptible hosts may
colitis (Cong et al., 1998, 2000). A CD8 T cell line, spe-provide a superantigenic stimulus pertinent to Crohn’s
cific for a mycobacterial heat shock protein, was alsodisease pathogenesis.
found to cause colitis upon cell transfer (Steinhoff et al.,
1999). However, with this single exception, the relevantIntroduction
target bacterial target antigens have not been identified.
Recently, our laboratory applied representational dif-Inflammatory bowel disease (IBD) is a family of disease
ference analysis (RDA) to identify microbial DNA seg-characterized by dysfunction of mucosal T cells, abnor-
ments specific for CD lesional mucosa versus adjacentmal cytokine production, cellular inflammation, and ulti-
uninvolved mucosa (Sutton et al., 2000). This searchmate damage to the intestinal lining (Podolsky, 1991).
resulted in the isolation of I2, a homolog of the tetRClinically, IBD is subdivided into Crohn’s disease (CD)
bacterial transcription factor family. Quantitative PCRand ulcerative colitis (UC). Th1-type helper cell activity
established that the I2 sequence was specifically pres-has been implicated in the disease-specific mucosal
ent in CD lesions compared to histologically uninvolvedinflammation in CD, and UC is characterized by Th2-
CD mucosa or other colonic specimens. In addition,like response (Mullin et al., 1992; Breese et al., 1993;
serum antibody studies revealed that IgA seroreactivityFuss et al., 1996). Currently, the cause of these diseases
to a recombinant I2 protein was CD specific. Theseis unknown, but recent evidence highlights two general
findings implicated a novel I2-bearing organism as apathologic processes: host genetic factors that increase
candidate for bacterial pathogen in Crohn’s disease.the susceptibility to disease and abnormal response of
An IBD animal model system involving the putativethe host to enteric bacteria. Family studies have docu-
I2 organism would offer an important opportunity tomented that susceptibility to UC and CD are in part
address major issues related to the regulation of theheritable traits (Roth et al., 1989; Peeters et al., 1997;
response to defined bacterial antigens in normal miceAkolkar et al., 1997). Similarly, targeted and systematic
and the potential role of such a defined antigen in IBDgenetic mapping studies have identified both shared
pathogenesis. Our findings indicate that a protein similarand disease-specific genetic loci (Hugot et al., 1996;
or identical to I2 is present in laboratory mice, sug-Duerr et al., 1998; Roussomoustakaki et al., 1997). En-
gesting that the putative I2 organism naturally colonizesteric bacteria have been implicated most prominently in
these mice. Furthermore, we show that I2 is a target ofCD, through disease sensitivity to alteration of fecal flow
a regulatory-type CD4 T cell response in normal mice.
Moreover, we present several lines of evidence that I24 Correspondence: jbraun@mednet.ucla.edu
is a novel class of T cell superantigen, suggesting that5 These authors contributed equally to this work.
I2 might provide a local superantigenic stimulus perti-6 Present address: Santarus Corporation, 12230 El Camino Real,
Suite 300, San Diego, California 92130. nent to pathogenesis of Crohn’s disease.
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Figure 1. I2 Sequence Is Present in Mouse Colon
C57BL/6J genomic DNA was assayed by PCR for I2 (285 bp) or GAPDH (340 bp). The control I2 mimic product was 606 bp. (A) SPF mice.
(B) Defined-flora mice.
Results cells incubated with antigen-presenting cells (APCs)
plus I2-GST (Figure 2B). Several other cytokines were
not detectably secreted, including IFN-, IL-4, andI2 Sequence Is Present in Mouse Tissue
The aim of this study was to establish the feasibility of TNF-. GST did not stimulate secretion of any of these
cytokines, indicating again that the response was I2studying the immunobiology of the Crohn’s disease-
associated I2 protein in the mouse. We first asked if the specific. SEB stimulated only modest IFN- secretion
under these culture conditions, as previously reportedI2 sequence was present in murine enteric tissues by
PCR. The 285 bp I2 product was observed in the distal (Assenmacher et al., 1998). APCs alone plus I2-GST did
not stimulate IL-10 production (data not shown). Thesesmall intestine, cecum, and proximal colon (Figure 1A).
This anatomic pattern was identical to that seen in hu- results indicate that I2 stimulates CD4 T cells from
SPF C57BL/6J mice to proliferate and promotes IL-10man enteric tissues (Sutton et al., 2000). The DNA se-
quences of molecular clones of these PCR products secretion.
In order to determine the cell type that was responsi-were identical to the I2 gene isolated from human
tissues. ble for the I2-stimulated IL-10 secretion, we utilized in-
tracellular flow cytometry and immunoflourescence mi-We next examined the I2 gene distribution in genomic
DNA prepared from tissue of defined-flora C57BL/6J croscopy. Intracellular flow cytometry indicated that IL-10
was secreted by B cells and CD4 T cells (Figure 2C).mice. In contrast to specific pathogen-free (SPF) mice,
the I2 sequence was undetectable in defined-flora mice Immunofluorescence microscopy of adherent cells in
the culture detected only rare IL-10-expressing cells(Figure 1B). Integrity of the I2 PCR reaction was con-
firmed by good product formation using the synthetic (data not shown). These results indicate that B cells and
CD4 T cells are the cell types responsible for the I2-I2 mimic, which yielded the expected 606 bp segment.
These results indicate that the I2-expressing microor- stimulated IL-10 secretion.
We wanted to address the possibility that the T cellganism colonizes mice in SPF but not defined-flora con-
ditions. stimulation by I2 was as a T cell mitogen rather than as
a conventional antigenic response. Experimentally, the
latter but not the former should be sensitive to inhibitionI2 Stimulates Proliferation of CD4 T Cells
by blocking antibodies to MHC class II. Relevant anti-and IL-10 Secretion in SPF Mice
body (anti-I-Ab) blocked the T cell proliferative responseTo determine whether I2 is an immunological target in
for both SEB and I2-GST (Figure 3A). This effect wasthe mouse, the naive T cell response to the I2 antigen
specific, because the irrelevant anti-I-Ad had minimalwas evaluated in C57BL6/J animals maintained in SPF
effect (Figure 3A). As expected, proliferation to the mito-conditions. CD4 T cells from SPF C57BL/6J mice dis-
gen Concanavalin A (Con A) was unaffected by the rele-played a dose-dependent proliferative response to I2-
vant antibody (anti-I-Ab) (Figure 3B). These results indi-GST (Figure 2A). This response was specific for the I2
cate that the I2 response was dependent on MHC classsequence, because a minimal response was observed
II-mediated recognition, and thus unlikely to reflect theeither to GST or to another fusion protein, I1-GST. In
action of a mitogen.addition, it is unlikely that the I2-GST response was
merely due to a low-level bacteria-derived contaminant
in this protein preparation, as I1-GST (a fusion protein I2 Induces CD4 T Cell Proliferation but Not IL-10
Secretion in Defined-Flora Miceexpressed and isolated under identical conditions as I2-
GST) induced no response. Staphylococcus enterotoxin Because defined-flora mice lack detectable enteric I2,
we predicted that the T cell response to I2 in these mice(SEB) was used as the positive control and yielded re-
sponses similar in magnitude to the maximal I2 response would be deficient or altered. Surprisingly, CD4 T cells
from defined-flora C57BL/6J mice had a proliferative(data not shown).
Substantial IL-10 was secreted in cultures of CD4 T response to I2-GST of similar magnitude to that ob-
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Figure 2. Recombinant I2 Stimulates Prolif-
eration and IL-10 Secretion by CD4 T Cells
from SPF C57BL/6J Mice
CD4 T cells from SPF C57BL/6J mice were
cultured with antigen-pulsed APCs (0, 2, 10,
15 g/ml; GST, I2-GST, I1-GST). SEB (1 g/
ml) was used as the positive control (data not
shown). (A) Proliferation (mean of triplicate
samples). (B) Cytokine secretion (mean of du-
plicate samples). (C) Intracellular IL-10. Cul-
tured cells were assayed for IL-10, CD4, and
B220 by flow cytometry. Data for 2g/ml anti-
gen are tabulated; similar results were ob-
served with other antigen concentrations.
served in SPF mice (Figure 4A). However, as shown in cordingly, we entertained the hypothesis that I2 is a
superantigen. Experimentally, T cell superantigens haveFigure 4B, defined-flora mice were distinguished by the
lack of detectable secretion of IL-10. There was a strong the following distinct properties: strong native responses
of naive T cells, strong T cell response in the absenceproliferative response to SEB (data not shown) and no
proliferative or cytokine response to GST. This finding of antigen processing, MHC class II dependence, and
selective expansion of T cells based upon expression ofsuggested that the I2-GST antigen is able to stimulate
CD4 T cells without prior exposure to enteric antigen. specific V genes. We examined each of these criteria.
The effects of I2 on naive or memory CD4 T cells
were compared first (Figure 5). Both naive and memoryBoth Naive and Memory CD4 T Cells Respond to I2
We were puzzled about how a strong I2 T cell response T cell populations had a strong proliferative and IL-10
response to I2-GST (Figures 5A–5C). This response wascould exist in defined-flora mice lacking enteric I2. Ac-
Figure 3. I2 Response Was Dependent on
MHC II-Mediated Recognition
CD4 T cells and antigen-pulsed APCs (I2-
GST, 5 g/ml) from SPF mice were cultured
in the presence and absence of 10g/ml anti-
I-Ab or anti-I-Ad. GST (5 g/ml) and SEB (1 g/
ml) were negative and positive control anti-
gens, respectively. Con A (1 g/ml) was used
as a model I-Ab-independent T cell mitogen.
After 48 hr of incubation, proliferation was
assayed by thymidine incorporation. (A) I2-
GST, GST, SEB. (B) Con A.
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Figure 4. Response of Cells from Defined-
Flora Mice
Cell cultures from defined-flora mice were as-
sayed for (A) proliferation of CD4 T cells and
(B) cytokine production. Data for 1g/ml anti-
gen are tabulated; similar results were ob-
served with other antigen concentrations.
specific, as both populations were unresponsive to GST. TCR-V5.1 and 5.2 Expression Was Restricted
in the Responding T Cell PopulationAnalysis of the response to SEB confirmed that the pop-
ulations were proliferation competent (data not shown). CD4 T lymphocytes were cocultured with antigen-
pulsed APCs in proliferation assay conditions, pulsed
with BrdU, and then analyzed by flow cytometry. TheThe CD4 T Cell Response to I2 Does Not Require
Antigen Processing proliferative response was determined for each CD4
V subset as reflected by the percentage of BrdU cellsFirst, the requirement for antigen processing was exam-
ined by evaluating the response to a panel of overlap- (Figure 7A). Compared to GST or no antigen, I2-GST
selectively activated T cells expressing V4, 5.1, 5.2, 6,ping synthetic I2 peptides. CD4 T cells and APCs pre-
viously antigen pulsed with synthetic peptide (0, 5, 20, and 7. I2-GST activated V5.1 and 5.2 in four out of
five experiments, and in these cases the V5.1 and 5.2and 50 g/ml) were cocultured for 48 hr and assayed for
proliferation and cytokine production. No proliferative response was the largest of the responding subsets.
Similar results were observed in C57BL/6J defined-floraor IL-10 responses were observed with any of these
peptides (data not shown). Second, we fixed APCs from mice (Figure 7C). In contrast, the V4, 6, and 7 responses
were either smaller and/or less consistent (one to threeSPF C57BL/6J mice with paraformaldehyde and then
pulsed them with either I2-GST or GST. Under these out of five experiments). Thus, we conclude that V5.1
and 5.2 are the primary V subsets activated by I2-GST.conditions, CD4 T cells still responded strongly to I2-
GST (Figure 6A); as expected, GST was nonstimulatory To validate our assay, we tested the V response to
SEB (Figure 7B). SEB strongly stimulated V3 cells and(Figure 6B). For a positive control of these conditions,
fixation profoundly impaired presentation of pigeon cy- moderately stimulated the response with V8.1, 8.2, and
V8.3. In BALB/C, the same V subsets respond to SEB,tochrome c (PPC) (Figure 6C). Collectively, the I2 re-
sponse appears to occur independent of antigen pro- although, in that strain, V8 predominates (Li et al.,
1999).cessing.
Figure 5. Activation of Naive and Memory CD4 T Cells upon I2 Stimulation
Naive and memory CD4 T cells (see Experimental Procedures) from SPF mice were cocultured with antigen-pulsed APCs. (A) Proliferation,
naive CD4 T cells. (B) Proliferation, memory CD4 T cells. (C) IL-10 production. Data for 5 g/ml antigen are tabulated; similar results were
observed with 1 g/ml antigen.
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Figure 6. The I2 Response Does Not Require Antigen Processing
(A and B) APCs, either normal or paraformaldehyde fixed, were antigen pulsed and cocultured with splenic CD4 T cells. (C) A.E7 PCC-
specific CD4 T cells were cocultured with antigen-pulsed APCs (normal or fixed). Proliferation was assayed for all groups by thymidine
incorporation.
V5 is uncommon among T cell populations of immu- ducing T cell population had a strong proliferative re-
sponse to antigen. This might reflect a mixed populationnologic interest, and we were able to obtain only one
of proliferative and IL-10-producing T cells in our cul-V5 hybridoma. The response (IL-2 secretion) of this
tures. Thus, both Th2 and Tr1 cells may be induced byV-defined cell line to Con A was weak and was unde-
I2 stimulation.tectable to I2-GST (data not shown). The evaluation of
The B cell effector subset responding to I2 also wasthe I2 response with clonal T cell populations thus will
characterized by moderate levels of IL-10 secretion. Therequire the generation of a suitable panel of cell lines.
cells may reflect involvement of B-1 cells, the primary
source of B cell-derived IL-10, and a major bacteria-Discussion
responsive mucosal B cell population (Bos et al., 2000).
IL-10 expression is important for mucosal immuno-In this study, we observed that the human CD-related
logic homeostasis (Asseman et al., 1999; Hagenbaughbacterial I2 gene is present in SPF but not defined-flora
et al., 1997; Berg et al., 1996). The basis of favored IL-C57BL/6J mice. Its gene product is a strong antigen for
10 expression in the mucosa remains unresolved. IL-10the nonimmunized splenic CD4 T cell population, and
is produced by a variety of cell types (Moore et al., 1993;the cytokine profile in SPF mice reveals antigen-depen-
O’Garra et al., 1992; Groux et al., 1997). However, in thedent IL-10 production by both CD4 T cells and B cells.
mucosa, its expression occurs at a frequency and atSeveral lines of evidence indicate that I2 is a T cell
levels that greatly exceed that observed for these cellsuperantigen. These findings provide evidence for an
types in nonmucosal compartments (Groux et al., 1997;in vivo T cell response to certain antigens of enteric
Hagenbaugh et al., 1997; Kakazu et al., 1999; Khoo etcommensal bacteria and that IL-10-expressing T cells
al., 1997; Rizzo et al., 1999). Many molecules induce IL-and B cells are generated as part of this response. The
10, including LPS, prostaglandins (PGE2), cannabinoids,issues raised by this study are the specificity and origin
and macrophage inflammatory protein-3 (MIP-3)of the I2 reactive T cells, the structural family of I2 as a
(Byrnes et al., 1999; Strassmann et al., 1994; Smith etT cell superantigen, and the potential relationship of the
al., 2000). Notably, most receptors for these ligands are
I2 response to the bacterial role in colitis pathogenesis.
Gi linked. Furthermore, costimulatory interactions in-
cluding B7RP-1/ICOS have been implicated in differenti-
Specificity of the I2 Response ation of Th2 (IL-4/IL-10) cells (Coyle and Gutierrez-
In SPF mice, CD4 T cells displayed a strong proliferative Ramos, 2001; Hutloff et al., 1999).
and IL-10 secretory response to I2-GST. No proliferation These observations frame the concept that mucosal
or IL-10 secretion was induced by negative control pro- immune homeostasis involves local mucosal production
teins (GST or an irrelevant I1-GST fusion protein), indi- of molecule(s) that promote IL-10 expression by resident
cating that the I2-GST response was I2 specific. Both immunoregulatory cells. The selective IL-10 secretion in
APCs and T cells were required, and both CD4 T cells the I2 response may reflect favored recruitment of IL-
and B cells contributed to I2-stimulated IL-10 production. 10 programmed cells (eg., mucosa-derived) or an addi-
The I2-responsive T cell effector subset was charac- tional I2 bioactivity signaling IL-10 induction. Future
terized by moderate IL-10 cytokine secretion and mini- studies will use our model immunologic system to iden-
mal production of IL-4. IL-4 expression is relatively tran- tify the molecules and the signaling pathway that leads
sient in Th2 cells (Swain, 1999), implicating this T cell to IL-10 induction.
population. Alternatively, the I2 response may reflect
other CD4 T cell subpopulations with this restricted cy- Localization of I2 Sequence in Mouse Intestine
tokine phenotype, such as Tr1 cells (Groux et al., 1997). The I2 sequence was predominantly detected in the
distal small bowel and proximal large bowel of SPF mice.Unlike the Tr1 cells reported previously, our IL-10-pro-
Immunity
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phisms in I2 isolated from human and mouse, the I2
organism would appear to be similar or identical.
I2 was strongly stimulatory for CD4 T cells from de-
fined-flora mice, indicating that a responsive population
exists in these mice, despite the absence of detectable
enteric I2 DNA. This response is unlikely to be due to
the presence of a crossreacting self or bacterial antigen,
because the character of the response to I2 is altered
in defined-flora mice. Curiously, the I2-induced IL-10
response was deficient in defined-flora mice. Mucosal
T cell and B-1 cell recruitment and differentiation are
disturbed in defined-flora versus SPF mice (Camerini et
al., 1998; Bos et al., 2000). Moreover, regulatory T cells
are dependent on recurrent antigenic stimulation and
favored by the intestinal microenvironment (Salomon et
al., 2000; Groux and Powrie, 1999; Buer et al., 1998).
The systemic immune system is exposed to mucosal
antigens and is programmed for IL-10 by intestinal den-
dritic cell transit to draining lymph nodes (Huang et al.,
2000). Since I2 is an intestinal antigen, this may account
for the splenic recovery of I2-responsive cells favoring
IL-10 expression.
CD4 T Cells Respond to I2 as a Superantigen
Several lines of evidence indicate that I2 is a superanti-
gen. First, the I2 response was dependent on MHC class
II presentation but not dependent on antigen pro-
cessing. These features are properties of superantigens
and are inconsistent with I2 stimulation as a T cell mito-
gen or a conventional T cell antigen, respectively. Sec-
ond, a series of I2 synthetic peptides were nonstimula-
tory, further indicating that I2 is not recognized as a
conventionally processed antigen. It should be noted
that only a limited number of peptides were evaluated,
and the particular ones used may have been unfavorable
for displaying the putative antigenic epitope. Third, it
was striking that there was a strong I2 response in non-
immunized mice, in mice lacking DNA encoding I2 anti-
gen, and in both the naive and memory T cell popula-
tions.Figure 7. TCR-V5.1 and 5.2 Expression Was Restricted in the Re-
Fourth, the I2-GST response was selective for CD4 Tsponding I2-GST-Specific T Cell Population
cells expressing certain V, notably 5.1 and 5.2. In theCD4 T cells from SPF and defined-flora C57BL/6J mice were cocul-
results, we present two limitations to this latter observa-tured with antigen-pulsed APCs (0.1g/ml; GST, I2-GST, SEB). After
48 hr, cultures were pulsed with 50 g/ml BrdU and then assayed tion. Compared to V3 T cells and SEB, the V5 and I2
by flow cytometry. The data are represented as a percentage of response was relatively small. The reduced response
BrdU, CD4, and V cells. To do this, PERCP-negative cells and does not reflect partial deletion and anergy of V5 by
CD4 cells were gated, and then the percentage of (BrdU and V the I2 bacterial commensal, since a similar response
cells)/(the total number of V cells) was calculated. The geometric
was seen in I2-deficient defined-flora mice. However, itmean of five experiments is shown here. (A) I2-GST, GST, no antigen
may reflect V5 depletion in C57BL/6J by Mlsf (Mtv-9(SPF mice). (B) SEB, no antigen, (SPF mice). (C) I2-GST, GST (de-
fined-flora mice). and Mtv-30) (Scherer et al., 1993). Other strain-specific
factors also affect the degree of stimulation, as reflected
in the present study by a relatively small response of
V8 T cells to SEB in C57BL/6 (compared to BALB/c orIn contrast, there was no detectable I2 in the intestine
of defined-flora mice. This lack of I2 DNA confirms our SJL). We further note that recombinant production of
I2-GST involved a protein denaturation step, which mayprevious observation that I2 is not a somatic mammalian
(human or mouse) sequence. It also suggests that the have reduced bioreactivity of I2-GST compared to SEB.
The other limitation was that a single available V5 TI2 organism is absent among the few bacterial species
colonizing our defined-flora mice. The presence of the cell hybridoma was not stimulated by I2-GST. However,
Con A stimulation of these hybridomas produced a rela-I2 sequence in SPF mice indicates that the I2 organism
is a normal colonist in the mouse as well as the human tively small IL-2 response, suggesting that these hybrid-
omas retained poor TCR-mediated signaling.and that the organism resides predominantly in the same
anatomic compartment (the ileum and proximal colon) In summary, four lines of positive evidence support
the characterization of I2-GST as a superantigen. Twoin both species. Since there were no sequence polymor-
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lines of evidence are not confirming but weak negatives environment important for homeostasis of normal mu-
cosa (De Winter et al., 1999).due to several technical considerations. Overall, our
findings indicate that I2-GST is a strong T cell antigen, The lesional association of I2 suggests that coloniza-
tion with the putative I2-expressing microorganism maymost fully explained by superantigen properties.
provide a local superantigenic stimulus pertinent to
pathogenesis of Crohn’s disease. In susceptible hosts,Relationship of I2 to Other Superantigens
aberrant Th1-like effector pathways triggered by entericMicrobial superantigens have been reported from bacte-
microorganisms are an important factor in colitis patho-rial and viral species. Bacterial superantigens have been
genesis. Our preliminary studies indeed demonstrate aobserved in Staphylococcus species, Streptococcus
strong I2 response in colitis-prone mice, which is distin-species, Mycoplasma arthritidis, and Yersinia pseudotu-
guished by a predominant Th1 effector phenotype (Dal-berculosis. Most belong to the pyrogenic toxin family,
wadi et al., 2000). Conversely, it is possible that anti-I2which includes staphylococcal entertoxins A through
antibodies observed in Crohn’s disease may block theE, toxic shock syndrome toxin (TSST-1), streptococcal
ability of I2 to interact with the normal regulatory popula-superantigen (SSA), and streptococcal pyrogenic exo-
tion. Accordingly, we speculate that effector T cell popu-toxins (SPE) A through C and F (Li et al., 1999). Pyrogenic
lations specific for the I2 antigen may contribute to initia-toxin superantigens share a two-domain structure, with
tion or amplification of mucosal inflammation in thesemultiple conformational constrained contact residues
colitis-prone strains. Validation of this idea will awaitfor MHC II and V. The Mtv viral superantigens of murine
isolation of I2-reactive T cell clones with these effectormammary tumor virus (MMTV) are encoded in the 3
profiles and their pathogenicity in an adoptive transferLTR, and are grouped into seven groups by TCR-V
model.specificity of the superantigen (Acha-Orbea and Mac-
Donald, 1995). They are structurally unrelated to bacte-
rial superantigens. For example, Mtv-7 is an Ii homolog, Experimental Procedures
and bears a distinct peptide motif (YNLNNSENS) with
Miceflanking protease cleavage sequences similar in position
C57BL/6J and BALB/c mice were purchased from The Jacksonand sequence to the MHC class II-binding CLIP peptide
Laboratory (Bar Harbor, ME), and SPF mice were housed in SPFmotif (MRMATPLLM) (Huber et al., 1996).
facilities of the UCLA Center for Health Sciences Vivarium. Defined-I2 lacks homology to the pyrogenic toxin family or the
flora C57BL/6J mice were colonized predominantly with a nonpatho-
Mtv superantigens. Moreover, the I2 gene lacks close genic Clostridium species and separately housed (Camerini et al.,
homologs among the available databases but is most 1998). Both male and female mice (8 weeks) were tested.
significantly related to the tetR family of transcriptional
regulators (Sutton et al., 2000). Interestingly, the specific
Antigens
Vs for I2 are activated by certain other superantigens. I2-GST, I1-GST, GST, staphylococcus enterotoxin (SEB), and pi-
The V5 subset responds to the Mycoplasma arthritidis geon cytochrome c (PPC) were used as antigens in each experiment.
mitogen (MAM), Mls-3, and Etc-1 (Kotzin et al., 1993). The 100 amino acid open reading frame (ORF) of I2 and the 115
amino acid ORF of I1 were subcloned into pGEX-KG (Guan andHowever, these superantigens activate additional V
Dixon, 1991). The GST proteins were produced in E. coli XL-1 bluesubsets distinct from I2 and, where their sequences are
(Stratagene, La Jolla, CA) transformed with pGEX-KG or I2-pGEX-known, lack homology to I2.
KG. Bacteria were grown to subconfluence, IPTG induced, and
Accordingly, I2 appears to be a novel structural class lysed, and the GST fusion proteins were purified according to the
of superantigen expressed by a normal colonist of the manufacturer’s instructions for soluble (GST) and inclusion body
human and mouse ileum. Many of the known superanti- fractions (I2-GST, I1-GST). The proteins were 90% pure by SDS-
PAGE and Coomassie blue straining (Guan and Dixon, 1991). Conca-gens have been implicated in the pathogenesis of cer-
navalin A (Con A), staphylococcus enterotoxin (SEB), and pigeontain diseases (Kotzin et al., 1993), and it is an intriguing
cytochrome c (PPC) were purchased from Sigma (St. Louis, MO).possibility that the superantigenic properties of I2 may
play a role in the pathogenesis of IBD. While certain
Reagentsenteric infections are associated with bacterial superan-
Anti-mouse CD8, anti-mouse B220, and sheep anti-rat IgG-coatedtigen production (Li et al., 1999; Miyoshi-Akiyama et al.,
magnetic beads were purchased from Dynal (Lake Success, NY).1995), I2 is unusual as an example of a superantigen
Other antibodies were purchased from PharMingen (San Diego, CA).
produced by a commensal enteric bacterial colonist. These included the mouse V TCR screening panel, fluorochrome
(FITC, PE, APC) conjugated anti-mouse -B220, -CD4, -CD8, -CD3,
-IL-10, I-Ab, I-Ad , CD45RB, CD62L; and a mouse IgG2a	 isotypeRelationship to IBD Pathogenesis
control. RPMI 1640 was purchased from Biowhittaker (Walkersville,Mucosal T cell populations reactive with commensal
MD). Fetal calf serum (FCS) was purchased from Hyclone (Logan,bacteria predominate with Tr1- and Th2-like cells and
Utah). 2-ME, L-glutamine, penicillin, and streptomycin were purchasedare blunted in terms of population abundance and ef-
from GIBCO-BRL (Gaithersburg, MD). IL-10, IL-4, TNF-, and IFN-
fector activity (Hiroi et al., 1995; Duchmann et al., 1999; cytokine kits were purchased from R&D (Minneapolis, MN). [Methyl-
Takahashi et al., 1999; Cong et al., 1998). Such popula- 3H]thymidine was purchased from ICN Pharmaceuticals (Irvine, CA).
Deoxyribonuclease I (DNase I) and bromodeoxyuridine (BrdU) weretions have been difficult to study due to the low level
purchased for Sigma (St. Louis, MO). Overlapping synthetic I2 pep-of the responses and the lack of defined bacterial anti-
tides included DLASAVGIQSGSIFHHFKSKD, FKSKDEILRAVMEETIgens. In the present study, superantigen activity of a
HYNTA, HYNTAMMRASIEEASTVRERV, VRERVLALIRCELQSIMGGprobable commensal colonic bacterium adds a new di-
SG, GGSGEAMAVLVYEWRSLSAE, and SLSAEGQAHVLALRDVY
mension to the enteric host-microbial interaction. In par- EQI. These were prepared and HPLC purified by Chiron Technolo-
ticular, IL-10 production by I2-reactive populations in gies (San Diego, CA) and were 24%–59% pure by mass spec-
troscopy.normal mice may contribute to the anti-inflammatory
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Cell Lines I2 and Mouse Glyceraldehyde 3-Phosphate
Dehydrogenase PCRThe A.E7 PCC CD4 T cell line was provided by Dr. C. Miceli (UCLA)
(Powell et al., 1999). A V5.1 and 5.2 specific T cell hybridomas Mouse genomic DNA was prepared from tissues by NucleoSpin
Tissue kit (Clonetech, Palo Alto, CA) (Piatak et al., 1993). The native(HB5) was provided by P. Allen (Washington University).
I2 and positive control mimic I2 PCR reactions yielded 285 and 606
bp products, respectively. The GAPDH PCR reactions yielded a 340Isolation of Antigen-Presenting Cells
bp product. The I2 primers were 5-TCTGCTCATACACGTCACG-3Red cell-depleted splenocytes were cultured with antigen at 2 

and 5-CCGTGGGCATCCAGTCCG-3. The GADPH primers were107 cells/4 ml for 12-16 hr at 37C, and then washed and irradiated
5-GCCAAGATGTCATTTGAATGGG-3 and 5-GAATCCATATAGAGGat 3000 rads (567.7 cGy/min for 5.5 min) prior to T cell coculture. In
CTGGG-3. All reactions were performed at 94C, 30 s for 1 cycle;some experiments, APCs were fixed with 0.5% paraformaldehyde
94C, 30 s, 65C, 30 s, 72C, 40 s for 39 cycles, and 72C, 10 min forfor 30 min prior to antigen culture.
1 cycle.
Purification of CD4 T Cells
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